| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 170,850 | 164,257 | 165,597 | 201,599 | | Cost of Revenue | 21,788 | 20,998 | 20,745 | 23,577 | | | Gross Profit | 149,062 | 143,259 | 144,852 | 178,022 | | | Operating Expenses | | Research Development | 34,722 | 35,510 | 37,696 | 38,777 | | Selling General and Administrative | 83,674 | 83,168 | 85,060 | 96,032 | | Non Recurring | 29,400 |
-
|
-
|
-
| | Others | 3,258 | 3,261 | 3,406 | 3,572 | | | | Total Operating Expenses | 151,054 |
-
|
-
|
-
| | | | Operating Income or Loss | (1,992) | 21,320 | 18,690 | 39,641 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,979 | 5,275 | (3,916) | (3,388) | | Earnings Before Interest And Taxes | (13) | 26,595 | 14,774 | 36,253 | | Interest Expense | (725) | 495 | 230 | (33) | | Income Before Tax | 712 | 26,100 | 14,544 | 36,286 | | Income Tax Expense | (2,237) | 5,641 | 4,615 | 7,115 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,949 | 20,459 | 9,929 | 29,171 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,949 | 20,459 | 9,929 | 29,171 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,949 | $20,459 | $9,929 | $29,171 |
|
0.01% Nasdaq 
Income Statement
